InvestorsHub Logo
icon url

Phantom Lord

06/14/19 7:15 PM

#26565 RE: Inoviorulez #26564

You don't think the pancreatic trial is going to have to go through more testing? The AML trial is way further along than the PC trial. Obviously the market opportunity is bigger for solid tumors. I don't need you to tell me that. My point is that to insinuate we will be bought out based on data from the first readout of the PC trial is wishful thinking.
icon url

microcapbiotech

06/14/19 8:49 PM

#26572 RE: Inoviorulez #26564

Nothing against anybody, but my blood boils every time I hear "buyout".

NO BUYOUTS, keep the profits from great success for US, the shareholders.

If I wanted to own Merck, or Pfizer, or Abbvie, I'd buy them.

The ONLY reason, "THEY" would buy MRKR is because they KNOW that MRKR will grow MUCH faster then they, as giants can, and it would be accretive to their earnings.

Let's keep those higher earning for ourselves.